Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval

Celik, Onder; Celik, Ebru; YILMAZ, ERCAN; Celik, Niluefer; TÜRKÇÜOĞLU, ILGIN; ULAŞ, MUSTAFA; Kumbak, Banu; Aktan, Erdal; Ozerol, Ibrahim

doi:10.1007/s00404-013-2804-1

Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval

Copy For Citation

Celik O., Celik E., YILMAZ E., Celik N., TÜRKÇÜOĞLU I., ULAŞ M., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.288, no.6, pp.1417-1422, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 288 Issue: 6
Publication Date: 2013
Doi Number: 10.1007/s00404-013-2804-1
Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1417-1422
Inonu University Affiliated: Yes

Abstract

To compare the serum and follicular fluid (FF) concentrations of stem cell factor (SCF) as well as the serum urocortin 1 (UCN1) concentration in gonadotropin-releasing hormone antagonist (GnRH-ant) and gonadotropin-releasing hormone agonist (GnRH-a) protocols for controlled ovarian hyperstimulation (COH) in IVF patients.